Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1991 Oct;66(4):264–267. doi: 10.1136/hrt.66.4.264

Vascular tone in heart failure: the neuroendocrine-therapeutic interface.

J G Cleland 1, C M Oakley 1
PMCID: PMC1024719  PMID: 1747275

Full text

PDF
264

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agostoni P. G., De Cesare N., Doria E., Polese A., Tamborini G., Guazzi M. D. Afterload reduction: a comparison of captopril and nifedipine in dilated cardiomyopathy. Br Heart J. 1986 Apr;55(4):391–399. doi: 10.1136/hrt.55.4.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aronow W. S., Lurie M., Turbow M., Whittaker K., Van Camp S., Hughes D. Effect of prazosin vs placebo on chronic left ventricular heart failure. Circulation. 1979 Feb;59(2):344–350. doi: 10.1161/01.cir.59.2.344. [DOI] [PubMed] [Google Scholar]
  3. BRAUNWALD E. THE CONTROL OF VENTRICULAR FUNCTION IN MAN. Br Heart J. 1965 Jan;27:1–16. doi: 10.1136/hrt.27.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bayliss J., Norell M. S., Canepa-Anson R., Reid C., Poole-Wilson P., Sutton G. Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin. Br Med J (Clin Res Ed) 1985 Jun 22;290(6485):1861–1865. doi: 10.1136/bmj.290.6485.1861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bayliss J., Norell M., Canepa-Anson R., Sutton G., Poole-Wilson P. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J. 1987 Jan;57(1):17–22. doi: 10.1136/hrt.57.1.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cleland J. G. ACE inhibitors in mild heart failure: first-line or second-line therapy? Eur Heart J. 1990 May;11 (Suppl 500):53–57. doi: 10.1093/eurheartj/11.suppl_d.53. [DOI] [PubMed] [Google Scholar]
  7. Cleland J. G., Dargie H. J., Ball S. G., Gillen G., Hodsman G. P., Morton J. J., East B. W., Robertson I., Ford I., Robertson J. I. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state. Br Heart J. 1985 Sep;54(3):305–312. doi: 10.1136/hrt.54.3.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cleland J. G., Dargie H. J., East B. W., Robertson I., Hodsman G. P., Ball S. G., Gillen G., Robertson J. I., Morton J. J. Total body and serum electrolyte composition in heart failure: the effects of captopril. Eur Heart J. 1985 Aug;6(8):681–688. doi: 10.1093/oxfordjournals.eurheartj.a061920. [DOI] [PubMed] [Google Scholar]
  9. Cleland J. G., Dargie H. J., Hodsman G. P., Ball S. G., Robertson J. I., Morton J. J., East B. W., Robertson I., Murray G. D., Gillen G. Captopril in heart failure. A double blind controlled trial. Br Heart J. 1984 Nov;52(5):530–535. doi: 10.1136/hrt.52.5.530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cleland J. G., Dargie H. J., McAlpine H., Ball S. G., Morton J. J., Robertson J. I., Ford I. Severe hypotension after first dose of enalapril in heart failure. Br Med J (Clin Res Ed) 1985 Nov 9;291(6505):1309–1312. doi: 10.1136/bmj.291.6505.1309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cleland J. G., Dargie H. J., Robertson I., Robertson J. I., East B. W. Total body electrolyte composition in patients with heart failure: a comparison with normal subjects and patients with untreated hypertension. Br Heart J. 1987 Sep;58(3):230–238. doi: 10.1136/hrt.58.3.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cleland J. G., Gillen G., Dargie H. J. The effects of frusemide and angiotensin-converting enzyme inhibitors and their combination on cardiac and renal haemodynamics in heart failure. Eur Heart J. 1988 Feb;9(2):132–141. doi: 10.1093/oxfordjournals.eurheartj.a062466. [DOI] [PubMed] [Google Scholar]
  13. Cleland J., Semple P., Hodsman P., Ball S., Ford I., Dargie H. Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure. Am J Med. 1984 Nov;77(5):880–886. doi: 10.1016/0002-9343(84)90530-8. [DOI] [PubMed] [Google Scholar]
  14. Coats A. J., Adamopoulos S., Meyer T. E., Conway J., Sleight P. Effects of physical training in chronic heart failure. Lancet. 1990 Jan 13;335(8681):63–66. doi: 10.1016/0140-6736(90)90536-e. [DOI] [PubMed] [Google Scholar]
  15. Cohn J. N., Archibald D. G., Ziesche S., Franciosa J. A., Harston W. E., Tristani F. E., Dunkman W. B., Jacobs W., Francis G. S., Flohr K. H. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Jun 12;314(24):1547–1552. doi: 10.1056/NEJM198606123142404. [DOI] [PubMed] [Google Scholar]
  16. Elkayam U., Weber L., Campese V. M., Massry S. G., Rahimtoola S. H. Renal hemodynamic effects of vasodilation with nifedipine and hydralazine in patients with heart failure. J Am Coll Cardiol. 1984 Dec;4(6):1261–1267. doi: 10.1016/s0735-1097(84)80147-3. [DOI] [PubMed] [Google Scholar]
  17. Fifer M. A., Colucci W. S., Lorell B. H., Jaski B. E., Barry W. H. Inotropic, vascular and neuroendocrine effects of nifedipine in heart failure: comparison with nitroprusside. J Am Coll Cardiol. 1985 Mar;5(3):731–737. doi: 10.1016/s0735-1097(85)80402-2. [DOI] [PubMed] [Google Scholar]
  18. Franciosa J. A., Weber K. T., Levine T. B., Kinasewitz G. T., Janicki J. S., West J., Henis M. M., Cohn J. N. Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo. Am Heart J. 1982 Sep;104(3):587–594. doi: 10.1016/0002-8703(82)90231-9. [DOI] [PubMed] [Google Scholar]
  19. Harris P. Congestive cardiac failure: central role of the arterial blood pressure. Br Heart J. 1987 Sep;58(3):190–203. doi: 10.1136/hrt.58.3.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. JOHNSON J. B., GROSS J. F., HALE E. Effects of sublingual administration of nitroglycerin on pulmonary-artery pressure in patients with failure of the left ventricle. N Engl J Med. 1957 Dec 5;257(23):1114–1117. doi: 10.1056/NEJM195712052572304. [DOI] [PubMed] [Google Scholar]
  21. Kremer D., Lindop G., Brown W. C., Morton J. J., Robertson J. I. Angiotensin-induced myocardial necrosis and renal failure in the rabbit: distribution of lesions and severity in relation to plasma angiotensin II concentration and arterial pressure. Cardiovasc Res. 1981 Jan;15(1):43–46. doi: 10.1093/cvr/15.1.43. [DOI] [PubMed] [Google Scholar]
  22. Leier C. V., Huss P., Magorien R. D., Unverferth D. V. Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure. Circulation. 1983 Apr;67(4):817–822. doi: 10.1161/01.cir.67.4.817. [DOI] [PubMed] [Google Scholar]
  23. Majid P. A., Sharma B., Taylor S. H. Phentolamine for vasodilator treatment of severe heart-failure. Lancet. 1971 Oct 2;2(7727):719–724. doi: 10.1016/s0140-6736(71)92098-8. [DOI] [PubMed] [Google Scholar]
  24. Mancini D. M., Davis L., Wexler J. P., Chadwick B., LeJemtel T. H. Dependence of enhanced maximal exercise performance on increased peak skeletal muscle perfusion during long-term captopril therapy in heart failure. J Am Coll Cardiol. 1987 Oct;10(4):845–850. doi: 10.1016/s0735-1097(87)80279-6. [DOI] [PubMed] [Google Scholar]
  25. Markham R. V., Jr, Gilmore A., Pettinger W. A., Brater D. C., Corbett J. R., Firth B. G. Central and regional hemodynamic effects and neurohumoral consequences of minoxidil in severe congestive heart failure and comparison to hydralazine and nitroprusside. Am J Cardiol. 1983 Oct 1;52(7):774–781. doi: 10.1016/0002-9149(83)90414-9. [DOI] [PubMed] [Google Scholar]
  26. McAlpine H. M., Morton J. J., Leckie B., Rumley A., Gillen G., Dargie H. J. Neuroendocrine activation after acute myocardial infarction. Br Heart J. 1988 Aug;60(2):117–124. doi: 10.1136/hrt.60.2.117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Packer M., Medina N., Yushak M., Lee W. H. Usefulness of plasma renin activity in predicting haemodynamic and clinical responses and survival during long term converting enzyme inhibition in severe chronic heart failure. Experience in 100 consecutive patients. Br Heart J. 1985 Sep;54(3):298–304. doi: 10.1136/hrt.54.3.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Richards A. M., Cleland J. G., Tonolo G., McIntyre G. D., Leckie B. J., Dargie H. J., Ball S. G., Robertson J. I. Plasma alpha natriuretic peptide in cardiac impairment. Br Med J (Clin Res Ed) 1986 Aug 16;293(6544):409–412. doi: 10.1136/bmj.293.6544.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Riegger G. A., Haeske W., Kraus C., Kromer E. P., Kochsiek K. Contribution of the renin-angiotensin-aldosterone system to development of tolerance and fluid retention in chronic congestive heart failure during prazosin treatment. Am J Cardiol. 1987 Apr 1;59(8):906–910. doi: 10.1016/0002-9149(87)91117-9. [DOI] [PubMed] [Google Scholar]
  30. Rouleau J. L., Bichet D., Kortas C. Atrial natriuretic peptide in congestive heart failure: postural changes and reset with chronic captopril therapy. Am Heart J. 1988 May;115(5):1060–1067. doi: 10.1016/0002-8703(88)90077-4. [DOI] [PubMed] [Google Scholar]
  31. Rouleau J. L., Warnica J. W., Burgess J. H. Prazosin and congestive heart failure: short- and long-term therapy. Am J Med. 1981 Jul;71(1):147–152. doi: 10.1016/0002-9343(81)90282-5. [DOI] [PubMed] [Google Scholar]
  32. Swedberg K., Eneroth P., Kjekshus J., Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation. 1990 Nov;82(5):1730–1736. doi: 10.1161/01.cir.82.5.1730. [DOI] [PubMed] [Google Scholar]
  33. Tan L. B., Murray R. G., Littler W. A. Felodipine in patients with chronic heart failure: discrepant haemodynamic and clinical effects. Br Heart J. 1987 Aug;58(2):122–128. doi: 10.1136/hrt.58.2.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Watkins L., Jr, Burton J. A., Haber E., Cant J. R., Smith F. W., Barger A. C. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. J Clin Invest. 1976 Jun;57(6):1606–1617. doi: 10.1172/JCI108431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wilson J. R., Ferraro N. Circulatory improvement after hydralazine or isosorbide dinitrate administration in patients with heart failure. Effect on metabolic responses to submaximal exercise. Am J Med. 1981 Oct;71(4):627–633. doi: 10.1016/0002-9343(81)90216-3. [DOI] [PubMed] [Google Scholar]
  36. Wilson J. R., Ferraro N., Wiener D. H. Effect of the sympathetic nervous system on limb circulation and metabolism during exercise in patients with heart failure. Circulation. 1985 Jul;72(1):72–81. doi: 10.1161/01.cir.72.1.72. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES